Invention Grant
- Patent Title: Thienopyranones as kinase inhibitors
- Patent Title (中): 噻嗪类作为激酶抑制剂
-
Application No.: US14041279Application Date: 2013-09-30
-
Publication No.: US09550790B2Publication Date: 2017-01-24
- Inventor: Guillermo A. Morales , Kevin Weber , Jessica Newblom , Joseph R. Garlich
- Applicant: SignalRx Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: SignalRx Pharmaceuticals, Inc.
- Current Assignee: SignalRx Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: TDW Patents & Consulting
- Agent Thomas D. Webster
- Main IPC: C07D495/04
- IPC: C07D495/04 ; A61K31/381 ; A61K31/5377 ; A61K31/69 ; A61K45/06 ; A61K47/48 ; C07K5/11 ; A61K31/538 ; C07F5/02
Abstract:
The invention relates to compounds of formula I (or pharmaceutically acceptable salts thereof) as defined herein, pharmaceutical compositions thereof, and their use in manufactures and methods for modulating biological processes including inhibition of kinase activity such as PI-3 kinase.
Public/Granted literature
- US20140073584A1 Thienopyranones as Kinase Inhibitors Public/Granted day:2014-03-13
Information query
